Pritesh Shah - Net Worth and Insider Trading

Pritesh Shah Net Worth

The estimated net worth of Pritesh Shah is at least $2 Million dollars as of 2024-04-27. Pritesh Shah is the Chief Growth Officer of NovoCure Ltd and owns about 124,511 shares of NovoCure Ltd (NVCR) stock worth over $2 Million. Details can be seen in Pritesh Shah's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Pritesh Shah has not made any transactions after 2023-11-07 and currently still holds the listed stock(s).

Transaction Summary of Pritesh Shah

To

Pritesh Shah Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Pritesh Shah owns 1 companies in total, including NovoCure Ltd (NVCR) .

Click here to see the complete history of Pritesh Shah’s form 4 insider trades.

Insider Ownership Summary of Pritesh Shah

Ticker Comapny Transaction Date Type of Owner
NVCR NovoCure Ltd 2023-11-07 Chief Commercial Officer

Pritesh Shah Latest Holdings Summary

Pritesh Shah currently owns a total of 1 stock. Pritesh Shah owns 124,511 shares of NovoCure Ltd (NVCR) as of November 7, 2023, with a value of $2 Million.

Latest Holdings of Pritesh Shah

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NVCR NovoCure Ltd 2023-11-07 124,511 12.64 1,573,196

Holding Weightings of Pritesh Shah


Pritesh Shah Form 4 Trading Tracker

According to the SEC Form 4 filings, Pritesh Shah has made a total of 36 transactions in NovoCure Ltd (NVCR) over the past 5 years, including 0 buys and 36 sells. The most-recent trade in NovoCure Ltd is the sale of 382 shares on November 7, 2023, which brought Pritesh Shah around $4,832.

Insider Trading History of Pritesh Shah

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Pritesh Shah Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Pritesh Shah Ownership Network

Ownership Network List of Pritesh Shah

No Data

Ownership Network Relation of Pritesh Shah


Pritesh Shah Owned Company Details

What does NovoCure Ltd do?

Who are the key executives at NovoCure Ltd?

Pritesh Shah is the Chief Commercial Officer of NovoCure Ltd. Other key executives at NovoCure Ltd include Chief Financial Officer Wilhelmus Cm Groenhuysen , President & CNS Cancers US Frank X Leonard , and Chief Human Resources Officer Michal Nath Puri .

NovoCure Ltd (NVCR) Insider Trades Summary

Over the past 18 months, Pritesh Shah made 6 insider transaction in NovoCure Ltd (NVCR) with a net sale of 25,323. Other recent insider transactions involving NovoCure Ltd (NVCR) include a net sale of 62,300 shares made by Frank X Leonard , a net sale of 32,769 shares made by Wilhelmus Cm Groenhuysen , and a net sale of 10,785 shares made by Ashley Cordova .

In summary, during the past 3 months, insiders sold 10,224 shares of NovoCure Ltd (NVCR) in total and bought 0 shares, with a net sale of 10,224 shares. During the past 18 months, 352,694 shares of NovoCure Ltd (NVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 352,694 shares.

NovoCure Ltd (NVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NovoCure Ltd Insider Transactions

No Available Data

Pritesh Shah Mailing Address

Above is the net worth, insider trading, and ownership report for Pritesh Shah. You might contact Pritesh Shah via mailing address: C/o Novocure Inc., 20 Valley Stream Parkway, Suite 300, Malvern Pa 19355.

Discussions on Pritesh Shah

No discussions yet.